Report: Autopsy found Cincinnati Bearcats offensive lineman Jeremiah Kelly had heart condition
ESPN reported on Tuesday that Jeremiah Kelly, an early enrollee who took part in spring practices with the Bearcats, had 'cardiac hypertrophy,' a thickening of the heart muscles. He was found unresponsive at his residence on April 22.
'The Bearcats football family is heartbroken by the sudden loss of this outstanding young man,' coach Scott Satterfield said in April. 'In the short time Jeremiah has spent with our team, he has made a real impact, both on the field and in our locker room. My prayers are with the Kelly family and those who had the pleasure of knowing Jeremiah.'
A freshman from Avon, Ohio, Kelly was a 6-foot-3, 320-pound offensive lineman who helped Avon High School to a 16-0 record and a state championship in 2024.
___
AP college football: https://apnews.com/hub/ap-top-25-college-football-poll and https://apnews.com/hub/college-football
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
23 minutes ago
- Yahoo
Cubs reach multi-year extension with president Jed Hoyer
Jed Hoyer is sticking around in Chicago. The Cubs reached a multi-year extension with their president of baseball operations on Monday afternoon, the team announced. Specifics of his new deal are not yet known, though his current contract with the Cubs was set to expire after this season. "Jed and his baseball operations staff have built a healthy player development organization and put an exciting, playoff contending team on the field," chairman Tom Ricketts said in a statement. "We are looking forward to the rest of hte season and to working with Jed for years to come." Hoyer has been with the Cubs since 2011, which makes him one of the longest-tenured front office executives anywhere in the league. He joined the franchise alongside then-president Theo Epstein as their general manager, and helped orchestrate the team's World Series win in 2016. That snapped a championship drought that went on for well over a century. Hoyer then took over as the team's president after the 2020 campaign when Epstein stepped down, and he signed a new five-year deal at the time. Hoyer largely broke up the Cubs' World Series group during his first season at the helm, too, sending away Anthony Rizzo, Javier Báez and Kris Bryant in quick succession ahead of the 2021 trade deadline. But now several years later, the Cubs are back in the mix with several new young starts — including NL MVP candidate Pete Crow-Armstrong, who was part of those trades four years ago. Hoyer also hired manager Craig Counsell to take over in 2024. Though the Cubs haven't made the playoffs under Hoyer's leadership in the role yet, the team holds a 62-43 record entering Monday's game against the Milwaukee Brewers. They are tied for first in the NL Central race with the Brewers, too, which is something they haven't won since 2020. While they aren't quite back to where they were a decade ago, the Cubs clearly believe that Hoyer is the man to get them there once again.
Yahoo
23 minutes ago
- Yahoo
Astros' Jeremy Pena nears return in latest injury update
The Houston Astros have run into an injury bug while experiencing a midseason slump in the week of the MLB trade deadline. Key players who are currently rehabbing injuries on the injury list include outfielder Yordan Alvarez, third baseman Isaac Paredes, as well as pitchers Cristian Javier and shortstop Jeremy Pena. Heading into the Astros series against the Washington Nationals on Monday, Houston was able to give an update on Jeremy Pena, who's been rehabbing a small rib fracture he sustained after getting hit by a pitch against the Chicago Cubs on June 27. According to The Athletic's Chandler Rome, Pena hit against live pitching at the Astros' Florida Complex over the weekend and will be returning to practice in Houston before their series against the Nationals. This is great for the Astros as they haven't been able to find the same success in July as they did in previous months. They have a record of 10-12 this month. Before Jeremy Pena went down with the injury, he was having the best season of his young career. He was elected as a 2025 All-Star while posting a .322 batting average, .278 on-base percentage, .867 OPS, and 4.5 WAR, hitting 11 home runs and 40 RBI through 82 games this season. Houston hasn't made a set time for Pena to return to the lineup, but he's expected to come back before the end of the month.
Yahoo
23 minutes ago
- Yahoo
Cellectis to Report Second Quarter 2025 Financial Results on August 4, 2025
NEW YORK, July 28, 2025 (GLOBE NEWSWIRE) -- Cellectis (the 'Company') (Euronext Growth: ALCLS- NASDAQ: CLLS), a clinical-stage biotechnology company using its pioneering gene-editing platform to develop life-saving cell and gene therapies, today announced that it will report financial results for the second quarter 2025 ending June 30, 2025 on Monday August 4, 2025 after the close of the US market. The publication will be followed by an investor conference call and webcast on Tuesday August 5, 2025 at 8:00 AM ET / 2:00 PM CET. The call will include the Company's second quarter results and an update on business activities. Details for the call are as follows: Dial in information: Domestic: +1-800-343-5172 International: +1-203-518-9856 Conference ID: CLLSQ2 Webcast Link: About Cellectis Cellectis is a clinical-stage biotechnology company using its pioneering gene-editing platform to develop life-saving cell and gene therapies. The company utilizes an allogeneic approach for CAR T immunotherapies in oncology, pioneering the concept of off-the-shelf and ready-to-use gene-edited CAR T-cells to treat cancer patients, and a platform to develop gene therapies in other therapeutic indications. With its in-house manufacturing capabilities, Cellectis is one of the few end-to-end gene editing companies that controls the cell and gene therapy value chain from start to finish. Cellectis' headquarters are in Paris, France, with locations in New York and Raleigh, NC. Cellectis is listed on the Nasdaq Global Market (ticker: CLLS) and on Euronext Growth (ticker: ALCLS). To find out more, visit and follow Cellectis on LinkedIn and X. TALEN® is a registered trademark owned by Cellectis. For further information on Cellectis, please contact: Media contacts: Pascalyne Wilson, Director, Communications, + 33 (0)7 76 99 14 33, media@ Patricia Sosa Navarro, Chief of Staff to the CEO, +33 (0)7 76 77 46 93 Investor Relations contact: Arthur Stril, Chief Financial Officer & Chief Business Officer, investors@ Attachment 20250728_Q2 2025 earnings call announcement_ENGLISHError while retrieving data Sign in to access your portfolio Error while retrieving data Error while retrieving data Error while retrieving data Error while retrieving data
